Bazaar Alan Lee 4
4 · PDL BIOPHARMA, INC. · Filed Nov 20, 2020
Insider Transaction Report
Form 4
Bazaar Alan Lee
Director
Transactions
- Exercise/Conversion
Common stock
2020-11-18$1.71/sh+37,080$63,407→ 70,515 total - Sale
Common stock
2020-11-20$2.42/sh−33,435$81,003→ 10,438 total - Tax Payment
Common stock
2020-11-18$2.38/sh−26,642$63,408→ 43,873 total - Exercise/Conversion
Stock Option (right to buy)
2020-11-18$1.71/sh−37,080$63,407→ 0 totalExercise: $1.71From: 2021-04-17Exp: 2030-04-17→ Common stock (37,080 underlying)
Footnotes (1)
- [F1]On May 21, 2020, the Company completed the distribution to its stockholders of its shares of common stock in Evofem Biosciences, Inc., which resulted in a $0.58 reduction to the exercise price of the stock option at such time pursuant to the Company's wind-down retention plan. On October 1, 2020, the Company completed the distribution to its stockholders of its shares of common stock in LENSAR, Inc., which resulted in a $0.78 reduction to the exercise price of the stock option at such time pursuant to the Company's wind-down retention plan.